Today: 10 June 2026
Browse Category

NYSE:IMAX 9 December 2025 - 29 May 2026

AMC Stock Rises as Summer Box Office Set to Test Theater Chain

AMC Stock Rises as Summer Box Office Set to Test Theater Chain

AMC Entertainment shares jumped 9.5% to $1.73 Friday, their biggest gain of the week, with trading volume nearly doubling from the previous session. The company drew over 5 million moviegoers worldwide during Memorial Day weekend, helped by Disney’s The Mandalorian and Grogu, which led the U.S. box office with $102 million. AMC reported a first-quarter net loss of $117.1 million and $3.96 billion in debt.
29 May 2026
····
IMAX stock price: shares steady in premarket after 14% pop on upbeat 2026 outlook

IMAX stock price: shares steady in premarket after 14% pop on upbeat 2026 outlook

IMAX shares rose 0.7% to $42.07 in premarket trading Friday after a 14.4% surge Thursday, following strong earnings and a 2026 box office forecast of $1.4 billion with 160–175 new system installs. Benchmark raised its price target to $44 and maintained a buy rating. The company reported 2025 revenue up 16% to $410.2 million. Fourth-quarter results included $22 million in one-time charges.
27 February 2026
·
IMAX Stock Soars on Analyst Upgrades and China Growth: What December 2025’s Rally Really Means

IMAX Stock Soars on Analyst Upgrades and China Growth: What December 2025’s Rally Really Means

IMAX shares closed at $38.50 on December 8, up 7.8% after new analyst upgrades and news of a deepened China partnership. The stock sits near a 52-week high, up over 30% in six months, outpacing the broader market. Consensus analyst price targets now range from $32 to $47, with most ratings at “Buy.” Management issued bullish three-year growth guidance at its recent Investor Day.
9 December 2025
··

Stock Market Today

  • UiPath Launches Coding Agents Platform, Gains UAE Cybersecurity Certification Amid Falling Shares
    June 10, 2026, 8:49 AM EDT. UiPath (NYSE:PATH) has introduced "UiPath for Coding Agents," enhancing automation deployment with better orchestration and governance. Additionally, it secured a key cybersecurity certification in the UAE, enabling the Automation Cloud's use by Tier 1 enterprises and government bodies. Despite these advances, PATH's stock trades near $10.75, down 32.3% year-to-date and 84.6% over five years. The developments boost UiPath's product capabilities and customer trust, critical for growth in software automation. Investors should watch for adoption rates of the new platform and potential UAE contracts that could impact future revenue. Currently, the stock trades 19% below analyst targets and is deemed undervalued by Simply Wall St, although momentum remains slightly negative.

Latest articles

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Shares Fall Again; Microsoft AI Cloud Agreement Still in Focus

10 June 2026
IREN plunged 8.73% to $54.02 Tuesday and slid another 3.72% premarket as investors weighed Wall Street’s bullish calls on its AI cloud buildout against a tech and crypto selloff; the stock’s fate now hinges on IREN’s ability to deliver Microsoft- and Nvidia-linked AI infrastructure on schedule, with the Microsoft contract at risk if timelines slip.
Go toTop